GlassScriptPhysician profile
Koscher Denee Jackson
NPI 1417350182
$2,044.68
in general payments reported to CMS, 2019-2025
13 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,213 · 2022: $139 · 2023: $84.89 · 2024: $124 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.05 | 2021-2025 | |
| Alkermes, INC. | $419.33 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $349.98 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $230.13 | 2021-2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $131.49 | 2021 | |
| Supernus Pharmaceuticals, INC. | $123.80 | 2021-2025 | Qelbree |
| Avanir Pharmaceuticals, INC. | $50.45 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $35.14 | 2021 | |
| Sunovion Pharmaceuticals INC. | $34.48 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.65 | 2021 | |
| Tris Pharma INC | $20.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.15 | 2021 | |
| Lundbeck LLC | $17.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Koscher Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.